Browse the full record of transactions filed by 김건수, Executive. Director active across 1 company, notably 큐로셀. Cumulatively, 17,943 disclosures have been recorded. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Kim Geon-soo is an Executive at Curecell. In this role, he is involved in managing operations and contributes to the overall strategy of the company. His expertise in the sector is an asset for the development of new products and innovation within the organization.